Previously, we have found that XPO1 inhibitors can restore the function of multiple tumor suppressive proteins including FOXO3a, p27, Par4 and p73, causing pancreatic cancer cell death in vitro and tumor inhibition in vivo [5]. This evidence concerns the gene XPO1 and familial pancreatic carcinoma.